Respiratory Intensive Care
What is Respiratory Intensive Care (Critical Care)?
Respiratory intensive care (or critical care medicine) is a specialty dedicated to the management of patients with acute life-threatening respiratory distress. It is provided in intensive care units (ICUs) or multidisciplinary critical care units, by a multidisciplinary team including intensivists, pulmonologists, specialized nurses, physiotherapists, and dietitians.
Reasons for admission to respiratory intensive care are numerous:
- Hypoxemic acute respiratory failure (severe pneumonia, ARDS, severe COVID-19, massive pulmonary embolism, cardiogenic pulmonary edema).
- Hypercapnic respiratory failure (COPD exacerbation, severe acute asthma, obesity-hypoventilation, myasthenia gravis, Guillain-Barré syndrome).
- Post-operative respiratory distress (complications after thoracic, upper abdominal, or neurosurgery).
- Ventilator weaning failure in tracheostomized patients.
- Polytrauma with pulmonary contusion or flail chest.
In Tunisia, our respiratory intensive care units are equipped with state-of-the-art technology and operate 24/7, following international guidelines (SRLF – French Language Society of Intensive Care, ESICM – European Society of Intensive Care Medicine).
Why is Hospitalization in Respiratory Intensive Care Necessary?
Acute respiratory distress is a life-threatening emergency because it leads to hypoxemia (low blood oxygen) and sometimes hypercapnia (elevated carbon dioxide), which can lead to:
- Multiple organ dysfunction syndrome (heart, brain, kidneys, liver) from tissue hypoxia.
- Respiratory acidosis (blood pH < 7.20) with risk of cardiac arrest.
- Respiratory muscle exhaustion (diaphragm, intercostals) leading to asphyxia.
Respiratory intensive care allows:
- Continuous monitoring of vital parameters (heart rate, blood pressure, oxygen saturation, invasive blood pressure).
- Providing appropriate respiratory support: high-flow oxygen therapy, non-invasive ventilation (NIV), or invasive mechanical ventilation (intubation).
- Treating the underlying cause (antibiotics, corticosteroids, diuretics, anticoagulants, pleural drainage...).
- Preventing and treating complications of immobilization and ventilation (pressure ulcers, nosocomial infections, thromboembolism, malnutrition).
Mortality in respiratory intensive care ranges from 10 to 40% depending on the pathology and severity. Rapid, high-quality management significantly improves prognosis.
What are the Signs of Respiratory Distress Requiring Intensive Care?
Signs of severe respiratory distress are:
- Severe dyspnea: inability to speak more than a few words, need to sit up to breathe.
- Tachypnea: respiratory rate > 30 cycles/minute.
- Use of accessory respiratory muscles: intercostal retractions, supraclavicular retractions, nasal flaring.
- Cyanosis: bluish discoloration of lips, fingers, or mucous membranes.
- Sweating, agitation, confusion or drowsiness (signs of cerebral hypoxia or hypercapnia).
- Desaturation: SpO2 < 90% on oxygen (or < 92% if COPD).
- Abnormal blood gas: PaO2 < 60 mmHg, PaCO2 > 45 mmHg with pH < 7.35.
- Signs of shock: arterial hypotension (SBP < 90 mmHg), tachycardia > 120/min, mottling.
In the presence of these signs, ICU admission is justified.
How is Respiratory Intensive Care Managed in Tunisia?
Management is based on a structured, multidisciplinary approach.
Admission and Initial Assessment
The patient is admitted directly to the ICU from the emergency department, a conventional care unit, or transferred from another hospital. The initial assessment includes:
- Complete clinical examination: level of consciousness (Glasgow Coma Scale), respiratory rate, lung auscultation, search for signs of shock.
- Arterial blood gas (repeated as needed): assessment of oxygenation (PaO2, PaO2/FiO2), ventilation (PaCO2, pH), and perfusion (lactate).
- Chest X-ray or rapid chest CT scan (if transport possible).
- Echocardiography (if available): search for a cardiogenic cause (left ventricular failure, pulmonary embolism).
- Extensive laboratory tests: CBC, platelets, CRP, procalcitonin, coagulation, troponin, NT-proBNP, renal and liver function tests, lactate.
Non-Invasive Ventilation (NIV)
Non-Invasive Ventilation (NIV) is the first-line technique in conscious, hemodynamically stable patients without signs of exhaustion. It delivers, via a facial or nasal mask, a positive pressure (inspiratory support) and PEEP (positive end-expiratory pressure). Indications:
- Acute hypercapnic COPD exacerbation (pH between 7.25 and 7.35).
- Cardiogenic pulmonary edema (CPE).
- Severe hypoxemic pneumonia (PaO2/FiO2 between 150 and 300).
- Decompensated severe sleep apnea.
- Prevention of intubation in the post-operative period.
NIV avoids intubation in 50 to 80% of cases, reduces mortality and length of hospital stay. Close monitoring is necessary because NIV failure (within 1-2 hours) requires immediate intubation.
High-Flow Nasal Oxygen (Optiflow)
High-flow nasal oxygen (Optiflow) delivers a heated, humidified air-oxygen mixture at up to 60 L/min. It is indicated in moderate to severe hypoxemia (PaO2/FiO2 between 200 and 300) without hypercapnia. It improves oxygenation, reduces work of breathing, and avoids intubation in 50-70% of cases.
Invasive Mechanical Ventilation (Intubation)
Endotracheal intubation (placement of a tube in the trachea) followed by invasive mechanical ventilation is indicated in cases of:
- NIV failure or contraindication (coma, cardiac arrest, septic shock, major airway secretions, vomiting).
- Severe hypoxemia (PaO2/FiO2 < 150) despite high-flow oxygen therapy.
- Severe respiratory acidosis (pH < 7.25) with hypercapnia.
- Respiratory distress with exhaustion of respiratory muscles.
- Need for airway protection (coma, cardiac arrest, massive hemorrhage).
Ventilator modes are adapted to the patient:
- VC (Volume Control): volume-controlled ventilation, used in the acute phase.
- PC (Pressure Control): pressure-controlled ventilation, better tolerated if leaks.
- SIMV (Synchronized Intermittent Mandatory Ventilation): synchronized ventilation, used during weaning.
- PSV (Pressure Support Ventilation): spontaneous ventilation with inspiratory assistance, used during weaning.
Basic settings: tidal volume 4-8 mL/kg, PEEP 5-15 cmH2O, FiO2 adjusted for SpO2 88-95%, respiratory rate 12-20/min. In ARDS, lung protection strategies (low tidal volume < 6 mL/kg, high PEEP, prone positioning, neuromuscular blockers) are applied.
Etiological Treatment
In parallel, the cause of respiratory distress is treated: antibiotics (pneumonia), corticosteroids (COPD, asthma, COVID-19-associated ARDS), diuretics (cardiogenic pulmonary edema), anticoagulants (pulmonary embolism), pleural drainage (effusion, pneumothorax), etc.
Ventilator Weaning and Extubation
Weaning from mechanical ventilation begins as soon as clinical conditions allow (improvement of the cause, normal consciousness, stable hemodynamics). The weaning protocol includes:
- Gradual reduction of sedation (if used).
- Spontaneous breathing trials (SBT): disconnection from the ventilator for 30 to 120 minutes, monitoring for signs of failure (respiratory rate > 35/min, desaturation < 90%, tachycardia > 140/min, hypertension or hypotension, agitation, sweating).
- Extubation (tube removal) after successful SBT and absence of swallowing disorders.
- Post-extubation NIV: indicated in cases of severe COPD, obesity, or previous extubation failure.
For patients with difficult weaning (multiple SBT failures, prolonged ventilator dependence > 14 days), a tracheostomy may be performed (surgical or percutaneous placement of a tracheal tube). Tracheostomy facilitates weaning, reduces nosocomial infections, and allows rehabilitation.
Supportive Care in Intensive Care
Respiratory intensive care is not limited to ventilation. Supportive care is essential:
- Artificial nutrition: enteral (nasogastric tube) or parenteral (intravenous) to meet high caloric needs (25-30 kcal/kg/day).
- Pressure ulcer prevention: pressure relief mattresses, position changes every 2 hours.
- Deep vein thrombosis (DVT) prevention: low molecular weight heparins (LMWH), compression stockings.
- Prevention of nosocomial infections: oral care, sterile tracheal suction, ventilator circuit changes.
- Sedation-analgesia (if necessary): propofol, midazolam, morphine, to reduce oxygen consumption and prevent exhaustion. Sedation scores (RASS) are used to adjust doses.
- Respiratory physiotherapy: bronchial clearance, early mobilization (bedside physical therapy).
- Early muscle rehabilitation: passive then active mobilization, in-bed cycling, electrical stimulation if necessary.
What are the Risks and Complications of Respiratory Intensive Care?
The ICU stay exposes patients to complications, especially with prolonged mechanical ventilation:
- Nosocomial infections: ventilator-associated pneumonia (VAP) (10-30% of patients ventilated > 48h), bacteremia, catheter-associated urinary tract infection, central line infection.
- Intubation-related complications: laryngeal injuries, tracheal stenosis, granuloma, hemorrhage.
- Barotrauma: pneumothorax, pneumomediastinum, subcutaneous emphysema (especially with high PEEP).
- Multiple organ dysfunction syndrome (septic shock, acute kidney injury, liver failure).
- Intensive Care Unit-Acquired Weakness (ICUAW): neuropathy and myopathy, delaying motor recovery (30-50% of patients ventilated > 7 days).
- Cognitive and psychological disorders: delirium (30-50% of patients), post-traumatic stress disorder (25%), depression, memory disorders.
- Pressure ulcers, deep vein thrombosis, pulmonary embolism.
- Prolonged ventilator dependence (difficult weaning) requiring tracheostomy and prolonged stay in step-down units.
What to Do After Respiratory Intensive Care? Post-ICU Rehabilitation
Discharge from intensive care (average duration 5 to 21 days depending on severity) marks the beginning of a post-ICU rehabilitation phase, often in a step-down unit, pulmonology department, or rehabilitation center:
- Intensive physical therapy: restoration of muscle strength, gait retraining (walker, cane), balance and coordination retraining.
- Respiratory physiotherapy: bronchial clearance, retraining of respiratory muscles, oxygen weaning.
- Speech therapy: swallowing rehabilitation (if post-intubation disorder), cognitive rehabilitation (memory, attention).
- Nutrition: resumption of oral feeding, nutritional supplements if persistent malnutrition.
- Psychologist / Psychiatrist: management of post-traumatic stress disorder, anxiety, depression.
- Long-term pulmonology and rehabilitative follow-up: consultation at 1, 3, 6, and 12 months, pulmonary function tests (PFTs), 6-minute walk test, control chest CT scan.
Why Choose Tunisia for Respiratory Intensive Care?
Tunisia has high-level intensivists and pulmonologists, trained in the best European centers (Paris, Lille, Marseille, Lyon, Geneva, Brussels). Intensive care equipment is modern: latest generation ventilators (Dräger, Hamilton, Maquet), invasive blood pressure monitoring, high-flow oxygen therapy (Optiflow), NIV devices, radiology and CT scan rooms dedicated to critically ill patients, specialized respiratory intensive care units.
Advantages
- Rapid admission times: ICU admission within 1 to 2 hours after medical decision (no stretcher waiting due to bed shortages, unlike some European countries).
- Standardized mortality: Mortality rates in Tunisian respiratory ICUs are comparable to European averages for common conditions (COPD, pneumonia, ARDS).
- All-inclusive packages: our packages include ICU hospitalization, mechanical ventilation (NIV or invasive), serial blood gas tests, imaging (CT scan, X-ray), laboratory tests, medications (antibiotics, corticosteroids, anticoagulants, sedation), daily respiratory physiotherapy, and the post-ICU rehabilitation program.
- Management of complex cases: Tunisia also accepts foreign patients for difficult ventilator weaning, tracheostomy, long-term post-COVID rehabilitation, at affordable rates.